Robert L. Sutherland

27.5k total citations · 3 hit papers
236 papers, 19.2k citations indexed

About

Robert L. Sutherland is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Robert L. Sutherland has authored 236 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Molecular Biology, 103 papers in Oncology and 81 papers in Genetics. Recurrent topics in Robert L. Sutherland's work include Estrogen and related hormone effects (68 papers), Cancer-related Molecular Pathways (56 papers) and Prostate Cancer Treatment and Research (27 papers). Robert L. Sutherland is often cited by papers focused on Estrogen and related hormone effects (68 papers), Cancer-related Molecular Pathways (56 papers) and Prostate Cancer Treatment and Research (27 papers). Robert L. Sutherland collaborates with scholars based in Australia, United States and United Kingdom. Robert L. Sutherland's co-authors include Elizabeth A. Musgrove, Susan M. Henshall, Christine L. Clarke, C. Elizabeth Caldon, Leigh C. Murphy, Roger J. Daly, Andrew Stone, Roger R. Reddel, Jane Barraclough and Rosemary E. Hall and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Robert L. Sutherland

234 papers receiving 18.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclin D as a therapeutic target in cancer

2011 1.1k citations Elizabeth A. Musgrove, C. Elizabeth Caldon et al. profile →
Biological determinants of endocrine resistance in breast cancer

2009 989 citations Elizabeth A. Musgrove, Robert L. Sutherland profile →
Progestin Regulation of Cellular Proliferation*

1990 543 citations Robert L. Sutherland et al. profile →

Peers

Countries citing papers authored by Robert L. Sutherland

Since Specialization

Citations

This map shows the geographic impact of Robert L. Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Sutherland more than expected).

Fields of papers citing papers by Robert L. Sutherland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Sutherland. The network helps show where Robert L. Sutherland may publish in the future.

Co-authorship network of co-authors of Robert L. Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Sutherland. A scholar is included among the top collaborators of Robert L. Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Sutherland. Robert L. Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease Outcome 2018 ·Clinical Cancer Research ·Carmela Ricciardelli, Tina Bianco‐Miotto, Shalini Jindal, Lisa M. Butler, Samuel Leung, Catriona M. McNeil, Sandra O’Toole, Esmaeil Ebrahimie, Ewan K.A. Millar, Andrew J. Sakko, (unknown), Sarah L. Vowler, David G. Huntsman, Stephen N. Birrell, Robert L. Sutherland, Carlo Palmieri, Theresa E. Hickey, Wayne D. Tilley	62
2	Transcription factor ATF3 links host adaptive response to breast cancer metastasis 2013 ·Journal of Clinical Investigation ·(unknown), Stephen J. McConoughey, Swati Jalgaonkar, Marino E. Leon, Anand S. Merchant, (unknown), Xin Yin, (unknown), Erik Zmuda, Sandra O’Toole, Ewan K.A. Millar, (unknown), Charles L. Shapiro, Michael C. Ostrowski, Robert L. Sutherland, Tsonwin Hai	96
3	TLE3 Expression Is Associated with Sensitivity to Taxane Treatment in Ovarian Carcinoma 2012 ·Cancer Epidemiology Biomarkers & Prevention ·Goli Samimi, Brian Z. Ring, D. T. Ross, Robert S. Seitz, Robert L. Sutherland, Philippa M. O’Brien, Neville F. Hacker, Warner K. Huh	17
4	Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells 2012 ·Molecular Cancer Therapeutics ·C. Elizabeth Caldon, C. Marcelo Sergio, Jian Kang, Anita Muthukaruppan, (unknown), Andrew Stone, Jane Barraclough, (unknown), Michael A. Black, Lance D. Miller, Julia M.W. Gee, (unknown), Robert L. Sutherland, Cristin G. Print, Elizabeth A. Musgrove	125
5	Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers 2011 ·Cancer Epidemiology Biomarkers & Prevention ·James Devaney, Clare Stirzaker, Wenjia Qu, Jenny Z. Song, Aaron L. Statham, Kate Patterson, Lisa G. Horvath, Bruce Tabor, Marcel W. Coolen, Toby Hulf, James G. Kench, Susan M. Henshall, Ruth Pe Benito, Anne‐Maree Haynes, Regina Mayor, Miguel A. Peinado, Robert L. Sutherland, Susan J. Clark	47
6	Pathways of chemotherapy resistance in castration-resistant prostate cancer 2011 ·Endocrine Related Cancer ·Kate Mahon, Susan M. Henshall, Robert L. Sutherland, Lisa G. Horvath	76
7	Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells 2010 ·Cancer Research ·Falko Hochgräfe, Luxi Zhang, Sandra O’Toole, Brigid C. Browne, Mark Pinese, (unknown), Gillian M. Lehrbach, David R. Croucher, Danny Rickwood, Alice Boulghourjian, Robert F. Shearer, Radhika Nair, Alexander Swarbrick, Dana Faratian, Peter Mullen, David J. Harrison, Andrew V. Biankin, Robert L. Sutherland, Mark J. Raftery, Roger J. Daly	141
8	High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtype 2010 ·Histopathology ·(unknown), Ibrahim M. Zardawi, Catriona M. McNeil, Ewan K.A. Millar, Duncan McLeod, Adrienne Morey, Paul Crea, Niamh Murphy, Mark Pinese, Elena López‐Knowles, Samantha R. Oakes, Christopher J. Ormandy, Min Qiu, Anne Hamilton, Andrew J. Spillane, Cheok Soon Lee, Robert L. Sutherland, Elizabeth A. Musgrove, Sandra O’Toole	48
9	Cell cycle proteins in epithelial cell differentiation: Implications for breast cancer 2010 ·Cell Cycle ·C. Elizabeth Caldon, Robert L. Sutherland, Elizabeth A. Musgrove	69
10	Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling 2009 ·Cancer Research ·(unknown), Brian Y. Lee, David A. Brown, Mark P. Molloy, Gavin Marx, Nick Pavlakis, Michael Boyer, Martin R. Stockler, Warren Kaplan, Samuel N. Breit, Robert L. Sutherland, Susan M. Henshall, Lisa G. Horvath	86
11	Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer 2009 ·Cancer Research ·Amelia A. Peters, Grant Buchanan, Carmela Ricciardelli, Tina Bianco‐Miotto, Margaret M. Centenera, Jonathan M. Harris, Shalini Jindal, Davendra Segara, Jia Li, Nicole L. Moore, Susan M. Henshall, Stephen N. Birrell, Gerhard A. Coetzee, Robert L. Sutherland, Lisa M. Butler, Wayne D. Tilley	309
12	Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel 2009 ·Journal of Clinical Oncology ·Ewan K.A. Millar, Peter Graham, Sandra A. O’Toole, Catriona M. McNeil, Lois Browne, Adrienne Morey, Sarah A. Eggleton, Julia Beretov, (unknown), Anne Capp, Elias Nasser, John H. Kearsley, Geoff P. Delaney, George Papadatos, C Fox, Robert L. Sutherland	247
13	Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. 2009 ·PubMed ·(unknown), Sandra O’Toole, Robert L. Sutherland, Elizabeth A. Musgrove	99
14	Androgen regulation of multidrug resistance‐associated protein 4 (MRP4/ABCC4) in prostate cancer 2008 ·The Prostate ·(unknown), James G. Kench, David J. Handelsman, George L. Scheffer, Phillip D. Stricker, (unknown), Robert L. Sutherland, Susan M. Henshall, John Allen, Lisa G. Horvath	58
15	An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown Origin 2005 ·Cancer Research ·Richard W. Tothill, Adam Kowalczyk, Danny Rischin, (unknown), Izhak Haviv, Ryan K. van Laar, Paul Waring, John Zalcberg, Robyn L. Ward, Andrew V. Biankin, Robert L. Sutherland, Susan M. Henshall, Kwun M. Fong, Jonathan R. Pollack, David D.L. Bowtell, Andrew Holloway	153
16	Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation withGRB2 expression 2000 ·International Journal of Cancer ·(unknown), A. Jayne Crew, Julia M.W. Gee, Rina Hui, Roger W. Blamey, J.F.R. Robertson, Robert I. Nicholson, Robert L. Sutherland, Roger J. Daly	55
17	Steroids, growth factors, and cell cycle controls in breast cancer 1991 ·Cancer treatment and research ·Elizabeth A. Musgrove, Robert L. Sutherland	27
18	Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. 1983 ·PubMed ·Robert L. Sutherland, Rosemary E. Hall, Ian W. Taylor	243
19	Non-steroidal antioestrogens : molecular pharmacology and antitumour activity 1981 ·Andalas University Repository (Andalas University) ·Robert L. Sutherland, V. Craig Jordan	42
20	ROP volume 41 issue 4 Cover and Front matter 1979 ·The Review of Politics ·(unknown), (unknown), (unknown), Waldemar Gurian, M Fitzsimons, (unknown), Robert L. Sutherland, Richard Vernon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact